Alto Neuroscience, Inc.
ANRO
$2.28
$0.010.44%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.80% | 254.28% | -- | 325.90% | 70.75% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 106.51% | 143.40% | -- | -- | 58.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -98.71% | 136.75% | -- | -- | 989.67% |
| Total Current Assets | 98.31% | 252.60% | -- | -- | 73.49% |
|
|
|||||
| Total Current Assets | 98.31% | 252.60% | -- | -- | 73.49% |
| Net Property, Plant & Equipment | 525.59% | 667.78% | -- | -- | -22.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8,300.00% | 150.75% | -- | -- | -89.09% |
| Total Assets | 104.95% | 259.92% | -- | -- | 70.35% |
|
|
|||||
| Total Accounts Payable | 47.02% | 28.25% | -- | -- | -33.13% |
| Total Accrued Expenses | 116.28% | 95.73% | -- | -- | -4.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 596.00% | 2,043.94% | -- | -- | -55.83% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 78.40% | 134.36% | -- | -- | 0.90% |
|
|
|||||
| Total Current Liabilities | 78.40% | 134.36% | -- | -- | 0.90% |
| Long-Term Debt | 17.21% | -32.07% | -- | -- | 4.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 68.59% | 68.77% | -- | -- | 2.13% |
|
|
|||||
| Common Stock & APIC | 5,297.56% | 5,987.02% | -- | -- | 133.57% |
| Retained Earnings | -79.82% | -87.37% | -- | -- | -89.29% |
| Treasury Stock & Other | -27.85% | -10.47% | -- | -- | -71.74% |
| Total Common Equity | 311.32% | 370.15% | -- | 602.80% | -86.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 95.86% |
| Preferred Stock, Others | -- | -- | -- | -- | -27.97% |
| Total Preferred Equity | -- | -- | -- | -- | 92.72% |
|
|
|||||
| Total Common Equity | 311.32% | 370.15% | -- | 602.80% | -86.62% |
| Total Preferred Equity | -- | -- | -- | -- | 92.72% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 112.85% | 340.12% | -- | 440.82% | 99.29% |
|
|
|||||